UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

O’REILLY AUTOMOTIVE, INC.

(Exact name of registrant as specified in its charter)

Missouri	000-21318	27-4358837
(State or other jurisdiction of	Commission file number	(I.R.S. Employer Identification No.)
incorporation or organization)

233 South Patterson Avenue

Springfield, Missouri 65802

(Address of principal executive offices, Zip code)

(417) 862-6708

(Registrant’s telephone number, including area code)

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)	Name of Each Exchange on which Registered
Common Stock,	$0.01 par value	ORLY	The Nasdaq Stock Market LLC
			(Nasdaq Global Select Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ☒   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐	Emerging growth company	☐
Non-accelerated filer	☐	Smaller reporting company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐   No  ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date:  Common stock, $0.01 par value - 63,318,293 shares outstanding as of August 1, 2022.  

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

FORM 10-Q

FOR THE QUARTER ENDED JUNE 30, 2022

TABLE OF CONTENTS

	Page
PART I - FINANCIAL INFORMATION	2
ITEM 1 - FINANCIAL STATEMENTS (UNAUDITED)	2
Condensed Consolidated Balance Sheets	2
Condensed Consolidated Statements of Income	3
Condensed Consolidated Statements of Comprehensive Income	4
Condensed Consolidated Statements of Shareholders’ Equity	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Financial Statements	7
ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	16
ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	23
ITEM 4 - CONTROLS AND PROCEDURES	23
PART II - OTHER INFORMATION	25
ITEM 1 - LEGAL PROCEEDINGS	25
ITEM 1A - RISK FACTORS	25
ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	25
ITEM 6 - EXHIBITS	26
SIGNATURE PAGES	27

1

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

	June 30, 2022		December 31, 2021
	(Unaudited)		(Note)
Assets
Current assets:
Cash and cash equivalents	$	253,904	$	362,113
Accounts receivable, net		330,672		272,562
Amounts receivable from suppliers		123,112		113,112
Inventory		4,005,384		3,686,383
Other current assets		86,800		70,092
Total current assets		4,799,872		4,504,262
Property and equipment, at cost		7,160,583		6,948,038
Less: accumulated depreciation and amortization		2,878,170		2,734,523
Net property and equipment		4,282,413		4,213,515
Operating lease, right-of-use assets		1,965,941		1,982,478
Goodwill		881,299		879,340
Other assets, net		138,164		139,112
Total assets	$	12,067,689	$	11,718,707
Liabilities and shareholders’ deficit
Current liabilities:
Accounts payable	$	5,258,712	$	4,695,312
Self-insurance reserves		137,281		128,794
Accrued payroll		106,814		107,588
Accrued benefits and withholdings		148,805		234,872
Income taxes payable		2,080		—
Current portion of operating lease liabilities		341,705		337,832
Other current liabilities		417,792		370,217
Total current liabilities		6,413,189		5,874,615
Long-term debt		4,669,833		3,826,978
Operating lease liabilities, less current portion		1,683,216		1,701,757
Deferred income taxes		203,744		175,212
Other liabilities		205,137		206,568
Shareholders’ equity (deficit):
Common stock, $0.01 par value:
Authorized shares – 245,000,000
Issued and outstanding shares –
63,752,833 as of June 30, 2022, and
67,029,042 as of December 31, 2021		638		670
Additional paid-in capital		1,286,651		1,305,508
Retained deficit		(2,391,108)		(1,365,802)
Accumulated other comprehensive loss		(3,611)		(6,799)
Total shareholders’ deficit		(1,107,430)		(66,423)
Total liabilities and shareholders’ deficit	$	12,067,689	$	11,718,707

Note:  The balance sheet at December 31, 2021, has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for complete financial statements.

See accompanying Notes to condensed consolidated financial statements.

2

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share data)

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Sales	$	3,670,737	$	3,465,601	$	6,966,748	$	6,556,500
Cost of goods sold, including warehouse and distribution expenses		1,786,019		1,639,223		3,373,958		3,089,327
Gross profit		1,884,718		1,826,378		3,592,790		3,467,173
Selling, general and administrative expenses		1,086,168		1,030,795		2,124,710		1,980,485
Operating income		798,550		795,583		1,468,080		1,486,688
Other income (expense):
Interest expense		(37,384)		(37,657)		(72,225)		(75,163)
Interest income		682		456		1,192		993
Other, net		(4,550)		2,952		(6,488)		4,643
Total other expense		(41,252)		(34,249)		(77,521)		(69,527)
Income before income taxes		757,298		761,334		1,390,559		1,417,161
Provision for income taxes		180,538		175,883		331,919		330,101
Net income	$	576,760	$	585,451	$	1,058,640	$	1,087,060
Earnings per share-basic:
Earnings per share	$	8.86	$	8.41	$	16.08	$	15.53
Weighted-average common shares outstanding – basic		65,116		69,618		65,840		69,997
Earnings per share-assuming dilution:
Earnings per share	$	8.78	$	8.33	$	15.94	$	15.39
Weighted-average common shares outstanding – assuming dilution		65,686		70,264		66,434		70,640

See accompanying Notes to condensed consolidated financial statements.

3

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(In thousands)

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Net income	$	576,760	$	585,451	$	1,058,640	$	1,087,060
Other comprehensive income (loss):
Foreign currency translation adjustments		(1,875)		3,707		3,188		(436)
Total other comprehensive (loss) income		(1,875)		3,707		3,188		(436)
Comprehensive income	$	574,885	$	589,158	$	1,061,828	$	1,086,624

See accompanying Notes to condensed consolidated financial statements.

4

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

(In thousands)

	For the Three Months Ended June 30, 2022
								Accumulated
				Additional				Other
	Common Stock			Paid-In		Retained		Comprehensive
	Shares	Par Value		Capital		Deficit		Loss		Total
Balance at March 31, 2022	65,920	$	659	$	1,309,071	$	(1,636,267)	$	(1,736)	$	(328,273)
Net income	—		—		—		576,760		—		576,760
Total other comprehensive loss	—		—		—		—		(1,875)		(1,875)
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes	11		—		5,692		—		—		5,692
Net issuance of common stock upon exercise of stock options	41		—		10,583		—		—		10,583
Share based compensation	—		—		5,717		—		—		5,717
Share repurchases, including fees	(2,219)		(21)		(44,412)		(1,331,601)		—		(1,376,034)
Balance at June 30, 2022	63,753	$	638	$	1,286,651	$	(2,391,108)	$	(3,611)	$	(1,107,430)
	For the Six Months Ended June 30, 2022
								Accumulated
				Additional				Other
	Common Stock			Paid-In		Retained		Comprehensive
	Shares	Par Value		Capital		Deficit		Loss		Total
Balance at December 31, 2021	67,029	$	670	$	1,305,508	$	(1,365,802)	$	(6,799)	$	(66,423)
Net income	—		—		—		1,058,640		—		1,058,640
Total other comprehensive income	—		—		—		—		3,188		3,188
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes	19		—		10,574		—		—		10,574
Net issuance of common stock upon exercise of stock options	91		1		26,021		—		—		26,022
Share-based compensation	—		—		11,811		—		—		11,811
Share repurchases, including fees	(3,386)		(33)		(67,263)		(2,083,946)		—		(2,151,242)
Balance at June 30, 2022	63,753	$	638	$	1,286,651	$	(2,391,108)	$	(3,611)	$	(1,107,430)
	For the Three Months Ended June 30, 2021
								Accumulated
				Additional				Other
	Common Stock			Paid-In		Retained		Comprehensive
	Shares	Par Value		Capital		Deficit		Loss		Total
Balance at March 31, 2021	69,735	$	697	$	1,274,033	$	(1,275,409)	$	(6,298)	$	(6,977)
Net income	—		—		—		585,451		—		585,451
Total other comprehensive income	—		—		—		—		3,707		3,707
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes	11		—		5,340		—		—		5,340
Net issuance of common stock upon exercise of stock options	130		1		23,926		—		—		23,927
Share based compensation	—		—		5,887		—		—		5,887
Share repurchases, including fees	(743)		(7)		(13,823)		(385,811)		—		(399,641)
Balance at June 30, 2021	69,133	$	691	$	1,295,363	$	(1,075,769)	$	(2,591)	$	217,694
	For the Six Months Ended June 30, 2021
								Accumulated
				Additional				Other
	Common Stock			Paid-In		Retained		Comprehensive
	Shares	Par Value		Capital		Deficit		Loss		Total
Balance at December 31, 2020	71,123	$	711	$	1,280,841	$	(1,139,139)	$	(2,155)	$	140,258
Net income	—		—		—		1,087,060		—		1,087,060
Total other comprehensive loss	—		—		—		—		(436)		(436)
Issuance of common stock under employee benefit plans, net of forfeitures and shares withheld to cover taxes	22		—		9,430		—		—		9,430
Net issuance of common stock upon exercise of stock options	206		2		33,770		—		—		33,772
Share-based compensation	—		—		11,799		—		—		11,799
Share repurchases, including fees	(2,218)		(22)		(40,477)		(1,023,690)		—		(1,064,189)
Balance at June 30, 2021	69,133	$	691	$	1,295,363	$	(1,075,769)	$	(2,591)	$	217,694

See accompanying Notes to condensed consolidated financial statements.

5

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

	For the Six Months Ended
	June 30,
	2022		2021
Operating activities:
Net income	$	1,058,640	$	1,087,060
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and intangibles		168,045		158,917
Amortization of debt discount and issuance costs		2,242		2,207
Deferred income taxes		28,302		21,922
Share-based compensation programs		12,702		12,575
Other		283		1,382
Changes in operating assets and liabilities:
Accounts receivable		(60,593)		(45,359)
Inventory		(318,756)		6,357
Accounts payable		563,012		398,785
Income taxes payable		12,013		12,408
Other		(73,917)		56,578
Net cash provided by operating activities		1,391,973		1,712,832
Investing activities:
Purchases of property and equipment		(228,921)		(222,607)
Proceeds from sale of property and equipment		8,222		4,566
Investment in tax credit equity investments		(4,080)		(1,768)
Other		(86)		(1,083)
Net cash used in investing activities		(224,865)		(220,892)
Financing activities:
Proceeds from borrowings on revolving credit facility		785,800		—
Payments on revolving credit facility		(785,800)		—
Proceeds from the issuance of long-term debt		847,314		—
Principal payments on long-term debt		—		(300,000)
Payment of debt issuance costs		(6,323)		(3,299)
Repurchases of common stock		(2,151,242)		(1,064,189)
Net proceeds from issuance of common stock		35,112		41,921
Other		(350)		(313)
Net cash used in financing activities		(1,275,489)		(1,325,880)
Effect of exchange rate changes on cash		172		(82)
Net (decrease) increase in cash and cash equivalents		(108,209)		165,978
Cash and cash equivalents at beginning of the period		362,113		465,640
Cash and cash equivalents at end of the period	$	253,904	$	631,618
Supplemental disclosures of cash flow information:
Income taxes paid	$	291,695	$	292,673
Interest paid, net of capitalized interest		68,318		76,788

See accompanying Notes to condensed consolidated financial statements.

6

O’REILLY AUTOMOTIVE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

June 30, 2022

NOTE 1 – BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of O’Reilly Automotive, Inc. and its subsidiaries (the “Company” or “O’Reilly”) have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  Operating results for the three and six months ended June 30, 2022, are not necessarily indicative of the results that may be expected for the year ended December 31, 2022.  For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

Principles of consolidation:

The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All inter-company balances and transactions have been eliminated in consolidation.    

NOTE 2 – VARIABLE INTEREST ENTITIES

The Company invests in certain tax credit funds that promote renewable energy.  These investments generate a return primarily through the realization of federal tax credits and other tax benefits.  The Company accounts for the tax attributes of its renewable energy investments using the deferral method.  Under this method, realized investment tax credits and other tax benefits are recognized as a reduction of the renewable energy investments.

The Company has determined its investment in these tax credit funds were investments in variable interest entities (“VIEs”).  The Company analyzes any investments in VIEs at inception and again if certain triggering events are identified to determine if it is the primary beneficiary.  The Company considers a variety of factors in identifying the entity that holds the power to direct matters that most significantly impact the VIEs’ economic performance including, but not limited to, the ability to direct financing, leasing, construction and other operating decisions and activities.  As of June 30, 2022, the Company had invested in four unconsolidated tax credit fund entities that were considered to be VIEs and concluded it was not the primary beneficiary of any of the entities, as it did not have the power to control the activities that most significantly impact the entities, and has therefore accounted for these investments using the equity method.  The Company’s maximum exposure to losses associated with these VIEs is generally limited to its net investment, which was $23.6 million as of June 30, 2022, and was included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets.    

NOTE 3 – FAIR VALUE MEASUREMENTS

The Company uses the fair value hierarchy, which prioritizes the inputs used to measure the fair value of certain of its financial instruments.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  The Company uses the income and market approaches to determine the fair value of its assets and liabilities.  The three levels of the fair value hierarchy are set forth below:

● Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

● Level 2 – Inputs other than quoted prices in active markets included within Level 1 that are observable for the asset or liability, either directly or indirectly.

● Level 3 – Unobservable inputs for the asset or liability.

Financial assets and liabilities measured at fair value on a recurring basis:

The Company invests in various marketable securities with the intention of selling these securities to fulfill its future unsecured obligations under the Company’s nonqualified deferred compensation plan.  See Note 10 for further information concerning the Company’s benefit plans.

The Company’s marketable securities were accounted for as trading securities and the carrying amount of its marketable securities were included in “Other assets, net” on the accompanying Condensed Consolidated Balance Sheets as of June 30, 2022, and

7

December 31, 2021.  The Company recorded a decrease in fair value related to its marketable securities in the amount of $6.4 million and an increase in fair value related to its marketable securities in the amount of $2.5 million for the three months ended June 30, 2022 and 2021, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.  The Company recorded a decrease in fair value related to its marketable securities in the amount of $9.2 million and an increase in fair value related to its marketable securities in the amount of $4.0 million for the six months ended June 30, 2022 and 2021, respectively, which were included in “Other income (expense)” on the accompanying Condensed Consolidated Statements of Income.  

The tables below identify the estimated fair value of the Company’s marketable securities, determined by reference to quoted market prices (Level 1), as of June 30, 2022, and December 31, 2021 (in thousands):

	June 30, 2022
	Quoted Priced in Active Markets		Significant Other		Significant
	for Identical Instruments		Observable Inputs		Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Marketable securities	$	47,468	$	—	$	—	$	47,468

	December 31, 2021
	Quoted Prices in Active Markets		Significant Other		Significant
	for Identical Instruments		Observable Inputs		Unobservable Inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Marketable securities	$	52,456	$	—	$	—	$	52,456

Non-financial assets and liabilities measured at fair value on a nonrecurring basis:

Certain long-lived non-financial assets and liabilities may be required to be measured at fair value on a nonrecurring basis in certain circumstances, including when there is evidence of impairment.  These non-financial assets and liabilities may include assets acquired in a business combination or property and equipment that are determined to be impaired.  As of June 30, 2022, and December 31, 2021, the Company did not have any non-financial assets or liabilities that had been measured at fair value subsequent to initial recognition.

Fair value of financial instruments:

The carrying amounts of the Company’s senior notes and unsecured revolving credit facility borrowings are included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021.  

The table below identifies the estimated fair value of the Company’s senior notes, using the market approach.  The fair value as of June 30, 2022, and December 31, 2021, was determined by reference to quoted market prices of the same or similar instruments (Level 2) (in thousands):

	June 30, 2022				December 31, 2021
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Senior Notes	$	4,669,833	$	4,501,833	$	3,826,978	$	4,135,629

The carrying amount of the Company’s unsecured revolving credit facility approximates fair value (Level 2), as borrowings under the facility bear variable interest at current market rates.  See Note 5 for further information concerning the Company’s senior notes and unsecured revolving credit facility.

The accompanying Condensed Consolidated Balance Sheets include other financial instruments, including cash and cash equivalents, accounts receivable, amounts receivable from suppliers and accounts payable.  Due to the short-term nature of these financial instruments, the Company believes that the carrying values of these instruments approximate their fair values.

8

NOTE 4 – LEASES

The Company leases certain office space, retail stores, distribution centers and equipment under long-term, non-cancelable operating leases.  The following table summarizes Total lease cost for the three and six months ended June 30, 2022 and 2021, which were primarily included in “Selling, general and administrative expenses” on the accompanying Condensed Consolidated Statements of Income (in thousands):

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Operating lease cost	$	91,089	$	87,363	$	180,798	$	174,582
Short-term operating lease cost		2,339		1,661		5,116		3,594
Variable operating lease cost		23,646		22,645		47,103		44,589
Sublease income		(1,277)		(1,185)		(2,422)		(2,383)
Total lease cost	$	115,797	$	110,484	$	230,595	$	220,382

The following table summarizes other lease-related information for the six months ended June 30, 2022 and 2021:

		For the Six Months Ended
		June 30,
		2022		2021
Cash paid for amounts included in the measurement of operating lease liabilities:
	Operating cash flows from operating leases	$	180,558	$	169,864
Right-of-use assets obtained in exchange for new operating lease liabilities			125,559		165,193

NOTE 5 – FINANCING

The following table identifies the amounts included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021 (in thousands):

	June 30, 2022		December 31, 2021
3.800% Senior Notes due 2022, effective interest rate of 3.845%	$	300,000	$	300,000
3.850% Senior Notes due 2023, effective interest rate of 3.851%		300,000		300,000
3.550% Senior Notes due 2026, effective interest rate of 3.570%		500,000		500,000
3.600% Senior Notes due 2027, effective interest rate of 3.619%		750,000		750,000
4.350% Senior Notes due 2028, effective interest rate of 4.383%		500,000		500,000
3.900% Senior Notes due 2029, effective interest rate of 3.901%		500,000		500,000
4.200% Senior Notes due 2030, effective interest rate of 4.205%		500,000		500,000
1.750% Senior Notes due 2031, effective interest rate of 1.798%		500,000		500,000
4.700% Senior Notes due 2032, effective interest rate of 4.740%		850,000		—
Total principal amount of debt		4,700,000		3,850,000
Less: Unamortized discount and debt issuance costs		30,167		23,022
Total long-term debt	$	4,669,833	$	3,826,978

Unsecured revolving credit facility:

The Company is party to a credit agreement dated June 15, 2021 (the “Credit Agreement”).  The Credit Agreement provides for a five-year $1.8 billion unsecured revolving credit facility (the “Revolving Credit Facility”) arranged by JPMorgan Chase Bank, N.A., which is scheduled to mature in June of 2026.  The Credit Agreement includes a $200 million sub-limit for the issuance of letters of credit and a $75 million sub-limit for swing line borrowings under the Revolving Credit Facility.  As described in the Credit Agreement governing the Revolving Credit Facility, the Company may, from time to time, subject to certain conditions, increase the aggregate commitments under the Revolving Credit Facility by up to $900 million, provided that the aggregate amount of the commitments does not exceed $2.7 billion at any time.

As of June 30, 2022, and December 31, 2021, the Company had outstanding letters of credit, primarily to support obligations related to workers’ compensation, general liability and other insurance policies, under the Credit Agreement in the amounts of $48.0 million and $84.0 million, respectively, reducing the aggregate availability under the Credit Agreement by those amounts.  Substantially all of these outstanding letters of credit have a one-year term from the date of issuance.  As of June 30, 2022, and December 31, 2021, the Company had no outstanding borrowings under its Revolving Credit Facility.

9

Borrowings under the Revolving Credit Facility (other than swing line loans) bear interest, at the Company’s option, at either an Alternate Base Rate or an Adjusted LIBO Rate (both as defined in the Credit Agreement) plus an applicable margin.  The Credit Agreement includes customary provisions to provide for the eventual replacement of LIBOR as a benchmark interest rate.  Swing line loans made under the Revolving Credit Facility bear interest at an Alternate Base Rate plus the applicable margin for Alternate Base Rate loans.  In addition, the Company pays a facility fee on the aggregate amount of the commitments under the Credit Agreement in an amount equal to a percentage of such commitments.  The interest rate margins and facility fee are based upon the better of the ratings assigned to the Company’s debt by Moody’s Investor Service, Inc. and Standard & Poor’s Ratings Services, subject to limited exceptions.  As of June 30, 2022, based upon the Company’s current credit ratings, its margin for Alternate Base Rate loans was 0.000%, its margin for Eurodollar Revolving Loans was 0.900% and its facility fee was 0.100%.

The Credit Agreement contains certain covenants, including limitations on subsidiary indebtedness, a minimum consolidated fixed charge coverage ratio of 2.50:1.00 and a maximum consolidated leverage ratio of 3.50:1.00.  The consolidated fixed charge coverage ratio includes a calculation of earnings before interest, taxes, depreciation, amortization, rent and non-cash share-based compensation expense to fixed charges.  Fixed charges include interest expense, capitalized interest and rent expense.  The consolidated leverage ratio includes a calculation of adjusted debt to earnings before interest, taxes, depreciation, amortization, rent and non-cash share-based compensation expense.  Adjusted debt includes outstanding debt, outstanding stand-by letters of credit and similar instruments, five-times rent expense and excludes any premium or discount recorded in conjunction with the issuance of long-term debt.  In the event that the Company should default on any covenant (subject to customary grace periods, cure rights and materiality thresholds) contained in the Credit Agreement, certain actions may be taken, including, but not limited to, possible termination of commitments, immediate payment of outstanding principal amounts plus accrued interest and other amounts payable under the Credit Agreement and litigation from lenders.  As of June 30, 2022, the Company remained in compliance with all covenants under the Credit Agreement.

In addition to the letters of credit issued under the Credit Agreement described above, as of June 30, 2022, the Company had additional outstanding letters of credit, primarily to support obligations under workers’ compensation, general liability and other insurance policies, in the amount of $60.9 million.  Substantially all of these letters of credit have a one-year term from the date of issuance and were not issued under the Company’s Credit Agreement or another committed facility.

Senior notes:

On June 15, 2022, the Company issued $850 million aggregate principal amount of unsecured 4.700% Senior Notes due 2032 (“4.700% Senior Notes due 2032”) at a price to the public of 99.684% of their face value with U.S. Bank Trust Company, National Association (f/k/a U.S. Bank National Association) (“U.S. Bank”) as trustee.  Interest on the 4.700% Senior Notes due 2032 is payable on June 15 and December 15 of each year, beginning on December 15, 2022, and is computed on the basis of a 360–day year.

As of June 30, 2022, the Company has issued and outstanding a cumulative $4.7 billion aggregate principal amount of unsecured senior notes, which are due between 2022 and 2032, with UMB Bank, N.A. and U.S. Bank as trustees.  Interest on the senior notes, ranging from 1.750% to 4.700%, is payable semi-annually and is computed on the basis of a 360-day year.  The $300 million aggregate principal amount of unsecured 3.800% Senior Notes due 2022 and the $300 million aggregate principal amount of unsecured 3.850% Senior Notes due 2023 were included in “Long-term debt” on the accompanying Condensed Consolidated Balance Sheet as of June 30, 2022, as the Company has the ability and intent to refinance these notes on a long-term basis.  None of the Company’s subsidiaries is a guarantor under the senior notes.  Each of the senior notes is subject to certain customary covenants, with which the Company complied as of June 30, 2022.      

NOTE 6 – WARRANTIES

The Company provides warranties on certain merchandise it sells with warranty periods ranging from 30 days to limited lifetime warranties. The risk of loss arising from warranty claims is typically the obligation of the Company’s suppliers. Certain suppliers provide upfront allowances to the Company in lieu of accepting the obligation for warranty claims.  For this merchandise, when sold, the Company bears the risk of loss associated with the cost of warranty claims.  Differences between supplier allowances received by the Company, in lieu of warranty obligations and estimated warranty expense, are recorded as an adjustment to cost of sales.  Estimated warranty costs, which are recorded as obligations at the time of sale, are based on the historical failure rate of each individual product line.  The Company’s historical experience has been that failure rates are relatively consistent over time and that the ultimate cost of warranty claims to the Company has been driven by volume of units sold as opposed to fluctuations in failure rates or the variation of the cost of individual claims.

10

The Company’s product warranty liabilities are included in “Other current liabilities” on the accompanying Condensed Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021; the following table identifies the changes in the Company’s aggregate product warranty liabilities for the six months ended June 30, 2022 (in thousands):

Warranty liabilities, balance at December 31, 2021	$	77,199
Warranty claims		(69,978)
Warranty accruals		74,055
Foreign currency translation		9
Warranty liabilities, balance at June 30, 2022	$	81,285

NOTE 7 – SHARE REPURCHASE PROGRAM

In January of 2011, the Company’s Board of Directors approved a share repurchase program. Under the program, the Company may, from time to time, repurchase shares of its common stock, solely through open market purchases effected through a broker dealer at prevailing market prices, based on a variety of factors such as price, corporate trading policy requirements and overall market conditions.  The Company’s Board of Directors may increase or otherwise modify, renew, suspend or terminate the share repurchase program at any time, without prior notice.  As announced on November 17, 2021, and May 16, 2022, the Company’s Board of Directors each time approved a resolution to increase the authorization amount under the share repurchase program by an additional $1.5 billion, resulting in a cumulative authorization amount of $20.3 billion.  The additional authorizations are effective for three years, beginning on their respective announcement date.

The following table identifies shares of the Company’s common stock that have been repurchased as part of the Company’s publicly announced share repurchase program for the three and six months ended June 30, 2022 and 2021 (in thousands, except per share data):

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2022		2021		2022		2021
Shares repurchased		2,219		743		3,386		2,218
Average price per share	$	620.27	$	537.25	$	635.40	$	479.69
Total investment	$	1,376,013	$	399,634	$	2,151,209	$	1,064,167

As of June 30, 2022, the Company had $1.4 billion remaining under its share repurchase authorization.  Subsequent to the end of the second quarter and through August 8, 2022, the Company repurchased 0.5 million additional shares of its common stock under its share repurchase program, at an average price of $659.29, for a total investment of $311.8 million.  The Company has repurchased a total of 89.4 million shares of its common stock under its share repurchase program since the inception of the program in January of 2011 and through August 8, 2022, at an average price of $214.81, for a total aggregate investment of $19.2 billion.

NOTE 8 – ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive income (loss) includes adjustments for foreign currency translations. The tables below summarize activity for changes in accumulated other comprehensive income (loss) for the three and six months ended June 30, 2022 and 2021 (in thousands):

	Foreign		Total Accumulated Other
	Currency (1)		Comprehensive Loss
Accumulated other comprehensive loss, balance at March 31, 2022	$	(1,736)	$	(1,736)
Change in accumulated other comprehensive loss		(1,875)		(1,875)
Accumulated other comprehensive loss, balance at June 30, 2022	$	(3,611)	$	(3,611)

	Foreign		Total Accumulated Other
	Currency (1)		Comprehensive Loss
Accumulated other comprehensive loss, balance at December 31, 2021	$	(6,799)	$	(6,799)
Change in accumulated other comprehensive loss		3,188		3,188
Accumulated other comprehensive loss, balance at June 30, 2022	$	(3,611)	$	(3,611)

11

	Foreign		Total Accumulated Other
	Currency (1)		Comprehensive Loss
Accumulated other comprehensive loss, balance at March 31, 2021	$	(6,298)	$	(6,298)
Change in accumulated other comprehensive loss		3,707		3,707
Accumulated other comprehensive loss, balance at June 30, 2021	$	(2,591)	$	(2,591)

	Foreign		Total Accumulated Other
	Currency (1)		Comprehensive Loss
Accumulated other comprehensive loss, balance at December 31, 2020	$	(2,155)	$	(2,155)
Change in accumulated other comprehensive loss		(436)		(436)
Accumulated other comprehensive loss, balance at June 30, 2021	$	(2,591)	$	(2,591)

(1) Foreign currency translation is not shown net of additional U.S. tax, as other basis differences of non-U.S. subsidiaries are intended to be permanently reinvested.

NOTE 9 – REVENUE